A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-Daily 10 cm2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)

This study is ongoing, but not recruiting participants.

Study NCT00622713 Information provided by Novartis

First Received: February 14, 2008 Last Updated: August 5, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	No date given